MAP3K8 Antibody (YA8246)

(Synonyms: AURA2; c-COT; COT; EST; ESTF; MEKK8; Tpl-2; TPL2)

MAP3K8 Antibody (YA8246) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to MAP3K8.

For research use only. We do not sell to patients.
  • Host:

    Mouse

  • Isotype:

    IgG

  • Application:

    IHC-P

  • Reactivity :

    Human, Mouse, Rat

  • Formulation:

    Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

  • Conjugation:
    Non-conjugated

Applications

Application
IHC-P Info
IHC-P: Immunohistochemistry-Paraffin
Dilution Ratio 1:150-500

Product Details

Description

MAP3K8 Antibody (YA8246) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to MAP3K8.

  • Host Mouse
  • Clonality Monoclonal
  • Species Reactivity
    Human, Mouse, Rat
  • Calculated Molecular Weight Predicted band size: 52.7 kDa
Immunogen

Human recombinant protein fragment corresponding to amino acids 277-461 of human MAP3K8 produced in E.coli.

Sensitivity

Endogenous

Purification

Affinity purified

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG

Product Properties

  • Appearance

    Solution

  • Formulation

    Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    MAP3K8 is required for lipopolysaccharide (LPS)-induced, TLR4-mediated activation of the MAPK/ERK pathway in macrophages, thus being critical for production of the pro-inflammatory cytokine TNF-alpha (TNF) during immune responses. Involved in the regulation of T-helper cell differentiation and IFNG expression in T-cells. Involved in mediating host resistance to bacterial infection through negative regulation of type I interferon (IFN) production. In vitro, activates MAPK/ERK pathway in response to IL1 in an IRAK1-independent manner, leading to up-regulation of IL8 and CCL4. Transduces CD40 and TNFRSF1A signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production. May also play a role in the transduction of TNF signals that activate JNK and NF-kappa-B in some cell types. In adipocytes, activates MAPK/ERK pathway in an IKBKB-dependent manner in response to IL1B and TNF, but not insulin, leading to induction of lipolysis. Plays a role in the cell cycle. Isoform 1 shows some transforming activity, although it is much weaker than that of the activated oncogenic variant

  • Subcellular Localization

    Cytoplasm

  • Expression


    Tissue_Specificity: Expressed in several normal tissues and human tumor-derived cell lines
    Induction: Up-regulated by IL12 in T-lymphocytes. Up-regulated in subcutaneous adipose tissue of obese individuals

  • Isoforms & Post-Translational Modification

    P41279 has two isomers: P41279-1: 52925 Da (predicted); P41279-2: 49620 Da (predicted).
    Autophosphorylated (PubMed:1833717, PubMed:8226782)

  • Subunit

    Forms a ternary complex with NFKB1/p105 and TNIP2

  • SwissProt ID

    P41279

  • Synonyms

    AURA2; c-COT; COT; EST; ESTF; MEKK8; Tpl-2; TPL2

MAP3K8 Antibody (YA8246) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00